Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
831 - 840 of 7540 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Precision medicine for Parkinson’s disease: The subtyping challenge
    2022
    RESTRICTED
    Title: Precision medicine for Parkinson’s disease: The subtyping challenge
    Author(s): Mark Frasier, Brian Fiske, Todd Sherer
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Vol: 14
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.1064057
    Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1064057/pdf
    Citation Count: 2
  • REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease
    2022
    RESTRICTED
    Title: REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease
    Author(s): A. Ahnaou, Drinkenburg WHIM
    Journal Name: Neuroscience & Biobehavioral Reviews
    Publisher: Elsevier BV
    Vol: 143
    Issue #:
    Start Page: 104897
    End Page: 104897
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104897
    Best OA location URL:
    Citation Count: 1
  • Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset
    2022
    RESTRICTED
    Title: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset
    Author(s): Jianhua Yang, Yuyuan Gao, Qingrui Duan, Yue Qiu, Shujun Feng, Cuijing Zhan, Hao Yin, Yuhu Zhang, Guixian Ma, Kun Nie, Limin Wang
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 105
    Issue #:
    Start Page: 90
    End Page: 95
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019
    Best OA location URL:
    Citation Count: 7
  • Revisiting levodopa for advanced Parkinson's disease.
    2022
    RESTRICTED
    Title: Revisiting levodopa for advanced Parkinson's disease.
    Author(s): Susan H. Fox
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 21
    Issue #: 12
    Start Page: 1063
    End Page: 1065
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5
    Best OA location URL:
    Citation Count: 1
  • Roc, the G-domain of the Parkinson’s disease-associated protein LRRK2
    2022
    RESTRICTED
    Title: Roc, the G-domain of the Parkinson’s disease-associated protein LRRK2
    Author(s): Yangshin Park, Jingling Liao, Quyen Q. Hoang
    Journal Name: Trends in Biochemical Sciences
    Publisher: Elsevier BV
    Vol: 47
    Issue #: 12
    Start Page: 1038
    End Page: 1047
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.tibs.2022.06.009
    Best OA location URL: http://manuscript.elsevier.com/S0968000422001633/pdf/S0968000422001633.pdf
    Citation Count: 5
  • Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
    2022
    RESTRICTED
    Title: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
    Author(s): Michael J. Soileau, Jason Aldred, Kumar Budur, Nahome Fisseha, Victor S.C. Fung, Anna Jeong, Thomas Kimber, Kevin J. Klos, Irene Litvan, Daniel O’Neill, Weining Robieson, Meredith Spindler, David Standaert, Saritha Talapala, Eleni Okeanis Vaou, Hui Zheng, Maurizio Facheris, Robert A. Hauser
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 21
    Issue #: 12
    Start Page: 1099
    End Page: 1109
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8
    Best OA location URL:
    Citation Count: 29
  • Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
    2022
    RESTRICTED
    Title: Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
    Author(s): David Snead, Mariusz Matyszewski, Andrea M. Dickey, Yu Xuan Lin, Andres E. Leschziner, Samara L. Reck-Peterson
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Vol: 29
    Issue #: 12
    Start Page: 1196
    End Page: 1207
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-022-00863-y
    Best OA location URL: https://www.nature.com/articles/s41594-022-00863-y.pdf
    Citation Count: 14
  • The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
    2022
    RESTRICTED
    Title: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
    Author(s): Laura I Sarasola, Claudia Llinás del Torrent, Andrea Pérez-Arévalo, Josep Argerich, Nil Casajuana-Martín, Andy Chevigné, Víctor Fernández-Dueñas, Sergi Ferré, L. Pardo, Francisco Ciruela
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Vol: 156
    Issue #:
    Start Page: 113896
    End Page: 113896
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896
    Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113896
    Citation Count: 8
  • The plight of loneliness in Parkinson's disease: New opportunities
    2022
    RESTRICTED
    Title: The plight of loneliness in Parkinson's disease: New opportunities
    Author(s): David Andrés González, Michelle Hyczy de Siqueira Tosin, Christopher G. Goetz
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 105
    Issue #:
    Start Page: 145
    End Page: 148
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.029
    Best OA location URL:
    Citation Count: 1
  • Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits
    2022
    RESTRICTED
    Title: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits
    Author(s): Ramzi G. Salloum, Ka Loong Kelvin Au, Michael S. Okun
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Vol: 79
    Issue #: 12
    Start Page: 1219
    End Page: 1219
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649
    Best OA location URL:
    Citation Count: 5
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year